Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9914f7d5da7a42d9b32aba1e6b44d64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0f4bc46e5481e2c8425e715f456b931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33b011e77b33662b8bf1f2ff2de7b661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d976e8c16727686d8ddc24ec4e96fa2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e77c0f6059f3a26fa895b65c7c9df1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6372f9f71c2d1c8cf483eb4fde24d1ad |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-64 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2013-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da62db8ed5ba735678a4c8028456c7d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b92512f767cd79e6757051a8e101ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b9bfac0a74498c5a86722f5c70ee10b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4dd3b2c9a98e2eba5ff18f272a2ce2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ee01f4da0eb1c62ff1abe54b4cf6aa |
publicationDate |
2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2928173-A1 |
titleOfInvention |
Compositions comprising benzothiophene derivatives and use thereof for treatment of estrogen-related medical disorders |
abstract |
Disclosed herein are methods for treatment of estrogen-related medical disorders. The methods of treatment may comprise administering to a subject in need of such treatment a composition comprising a therapeutically effective amount of at least one compound of formula (I) or a pharmaceutically acceptable salt thereof. |
priorityDate |
2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |